ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,436.44
-0.50%
Dow Jones
40,743.33
0.00%
US Dollar vs MXN
18.76915
0.01%
Brent Oil
80.425
2.37%
Bitcoin
66,069.49
-0.15%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
31/07/202407:05Business WireAmanda Rentfrow Joins Alliant Insurance Services in Atlanta
31/07/202407:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TTMITTM Technologies Inc
31/07/202407:03PR Newswire (US)Pacifica Hotels Chooses Schoox to Transform Training Across the Organization
31/07/202407:03PR Newswire (US)InMode Introduces IgniteRF The Complete Minimally Invasive Soft Tissue Contraction PlatformNASDAQ:INMDInMode Ltd
31/07/202407:03PR Newswire (US)Guidefitter Surges Forward with Record Outdoor Brand Partner Growth
31/07/202407:03PR Newswire (US)NC Humanities Seeks Six Communities to Host the Smithsonian Exhibition "Spark! Places of Innovation"
31/07/202407:02GlobeNewswire Inc.Ardelyx Announces Publication of Two Plain Language Summaries from XPHOZAH® (tenapanor) Clinical Trials in Current Medical Research and OpinionNASDAQ:ARDXArdelyx Inc
31/07/202407:02PR Newswire (US)ebb3 Standardizes on ControlUp's Digital Employee Experience Platform to Enhance Services for Customers Running Graphics Intensive Applications on VDI
31/07/202407:01Business WireMastercard Incorporated Second Quarter 2024 Financial Results Available on Company’s WebsiteNYSE:MAMasterCard Incorporated
31/07/202407:01Business WireUSAA Teams up With Aflac to Provide New Insurance Options for Members
31/07/202407:01PR Newswire (Canada)ViiV Healthcare announces positive data demonstrating 2-drug regimen DOVATO is as effective as 3-drug regimen BIKTARVY for maintenance therapy of HIV-1NYSE:PFEPfizer Inc
31/07/202407:01PR Newswire (US)Wingstop Inc. Reports Fiscal Second Quarter 2024 Financial ResultsNASDAQ:WINGWingstop Inc
31/07/202407:01PR Newswire (Canada)ViiV Soins de santé annonce des données positives montrant que la bithérapie DOVATO est aussi efficace que la trithérapie BIKTARVY pour le traitement d'entretien du VIH-1NYSE:PFEPfizer Inc
31/07/202407:01PR Newswire (US)Signature Bank Earns Spot No. 15 on Crain's List of Largest Banks in Chicago
31/07/202407:01GlobeNewswire Inc.Aspire Biopharma, Inc. Signs Letter of Intent to Create a Publicly Listed, Drug Delivery Company Through a Business Combination with PowerUp Acquisition Corp.NASDAQ:PWUPPowerUp Acquisition Corporation
31/07/202407:01GlobeNewswire Inc.Ironwall CEO Calls for Diligent Protection of Employees’ Personal Data in Wake of Recent Healthcare Organization Cyberattacks
31/07/202407:00GlobeNewswire Inc.Spectral AI Announces Continuing Progress in Development of Handheld DeepView SnapShot M® for Military Field UseNASDAQ:MDAIWSpectral AI Inc
31/07/202407:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GENEGenetic Technologies Ltd
31/07/202407:00GlobeNewswire Inc.Olaplex Holdings, Inc. Announces Participation in the Canaccord Genuity 44th Annual Growth Conference on August 14thNASDAQ:OLPXOlaplex Holdings Inc
31/07/202407:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SRDXSurModics Inc
31/07/202407:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DNPDNP Select Income Fund Inc
31/07/202407:00GlobeNewswire Inc.Achieve Life Sciences Announces FDA Grants Breakthrough Therapy Designation to Cytisinicline for the Treatment of E-Cigarette or Vaping Nicotine DependenceNASDAQ:ACHVAchieve Life Sciences Inc
31/07/202407:00GlobeNewswire Inc.TTM Technologies, Inc. Reports Second Quarter 2024 ResultsNASDAQ:TTMITTM Technologies Inc
31/07/202407:00GlobeNewswire Inc.electroCore to Announce Second Quarter June 30, 2024 Financial Results on Wednesday, August 7, 2024NASDAQ:ECORelectroCore Inc
31/07/202407:00Business WireFuzzy's Taco Shop® Debuts Two Hot Honey Chicken Menu Items for a Hot Fuzzy’s Summer
31/07/202407:00GlobeNewswire Inc.Immutep Quarterly Activities Report Q4 FY24NASDAQ:IMMPImmutep Ltd
31/07/202407:00Business WireWestern Asset Inflation-Linked Opportunities & Income Fund (WIW or “the Fund”; CUSIP: 95766R104) Announces Notification of Sources of DistributionsNYSE:WIWWestern Asset Inflation Linked Opportunities & Income Fund
31/07/202407:00Business WireMuenster Adds to Executive Leadership Team with New CFO and Sales Leadership
31/07/202407:00Business WireFICO Recognized as Trusted Cloud Provider by Cloud Security AllianceNYSE:FICOFair Isaac Inc
31/07/202407:00GlobeNewswire Inc.Bipartisan Senate Bill Seeks to Clarify that Implanted Active Middle Ear Hearing Devices are Prosthetics, Not Hearing Aids, Making Them Eligible for Medicare CoverageNASDAQ:COCHEnvoy Medical Inc

Su Consulta Reciente

USOTC
RHHBY
Roche (QX)
FX
EURMXN
Euro vs MXN
COIN
ETHUSD
Ethereum
NYSE
MCD
McDonalds
AMEX
XLF
Financial Select Sector
AMEX
XLV
Health Care Select Sector
USOTC
BASFY
BASF (QX)
NYSE
XOM
Exxon Mobil
NYSE
KO
Coca Cola
FX
EURUSD
Euro vs US Dollar
COIN
SOLUSD
Solana
SPI
SP500
S&P 500
USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
JPM
JP Morgan Chase
NASDAQ
TSLA
Tesla
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados